ad image

Vaccination

1 / 1
Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines
Intranasal Vaccines

Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines

Chad Costley, M.D.

BlueWillow Biologics

PAO-04-022-CL-15Apr 28, 2022
Merck & Co.
Vaccine

CDC Advisory Recommends Vaccination of Adults Ages 27-45 with GARDASIL®9 & Harmonization of Catch-up Vaccination for Males and Females Through Age 26

Merck & Co.

PR-M07-19-NI-004Jul 01, 2019
U.S. Food & Drug Administration
Influenza

Statement by FDA Commissioner Scott Gottlieb, M.D., on Preparations for the Upcoming Flu Season and Vaccinations

U.S. Food & Drug Administration

PR-M10-18-NI-008Oct 02, 2018
BioNTech
Collaboration

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza

BioNTech

PR-M09-18-NI-052Sep 18, 2018
FDA Grants Fast Track Status to Takeda’s Zika Vaccine Candidate
Fast Track

FDA Grants Fast Track Status to Takeda’s Zika Vaccine Candidate

Emilie Branch

Pharma's Almanac

PAO-M02-18-NI-003Feb 01, 2018
New Initiative to Accelerate Development of Universal Flu Vaccines Launches
Vaccine

New Initiative to Accelerate Development of Universal Flu Vaccines Launches

Nice Insight

PAO-M10-17-NI-046Oct 31, 2017
GSK Shingles Vaccine Recommended for Approval by FDA Panel

GSK Shingles Vaccine Recommended for Approval by FDA Panel

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M09-17-NI-027Sep 21, 2017
Recombinant Flu Vaccine Outperforms Egg-based Alternatives
Drug Delivery

Recombinant Flu Vaccine Outperforms Egg-based Alternatives

Nigel Walker

Nice Insight

PAO-M06-17-NI-019Jun 27, 2017
Breakthrough Drug Delivery Technology

Breakthrough Drug Delivery Technology

Nice Insight

PTV-M11-16-AP-022Apr 06, 2017
1 / 1